Physician profile
Lynne C Einbinder
NPI 1780687129
$5,571.81
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,547 · 2020: $1,246 · 2021: $1,225 · 2022: $1,154 · 2023: $372 · 2024: $28.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,363.92 | 2019-2023 | Aveir |
| Astrazeneca Pharmaceuticals LP | $865.50 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $433.22 | 2019-2022 | |
| Irhythm Technologies, INC. | $397.33 | 2020-2023 | Zio Xt Patch |
| Novartis Pharmaceuticals Corporation | $379.56 | 2019-2023 | |
| Boston Scientific Corporation | $244.07 | 2019-2022 | |
| Medtronic Vascular, INC. | $213.87 | 2019-2020 | |
| Amgen INC. | $213.23 | 2019-2023 | Repatha |
| Pfizer INC. | $201.97 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $187.76 | 2021-2022 | |
| Medtronic, INC. | $123.63 | 2021-2023 | Linq II |
| Philips North America LLC | $123.50 | 2022-2023 | |
| Amarin Pharma, INC. | $114.85 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.08 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $91.05 | 2019-2023 | Camzyos |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.22 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $64.42 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $47.86 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $41.66 | 2019 | |
| Daiichi Sankyo INC. | $41.17 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $34.69 | 2019-2021 | |
| Esperion Therapeutics, INC. | $30.78 | 2020-2023 | Nexletol |
| Angiodynamics, INC. | $28.05 | 2024 | Auryon Laser System 100-120 Vac |
| Sanofi-Aventis U.S. LLC | $27.52 | 2019-2020 | |
| Sensible Medical Innovations INC | $22.96 | 2019 | |
| G Medical Diagnostic Services, INC. | $18.36 | 2019 | |
| W. L. Gore & Associates, INC. | $16.79 | 2020 | |
| Impulse Dynamics (USA) INC. | $15.70 | 2022 | |
| Lundbeck LLC | $14.97 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $14.09 | 2022 | |
| Vifor Pharma, INC. | $14.03 | 2023 | Veltassa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynne Einbinder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.